{name}
{subtitle}
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.
city
~43 mi. (Tyler, Texas, +230 more cities)
facility
Research Site
biomarker
ER Positive, +1 more biomarker
drug
camizestrant, +3 more drugs
drug type
hormone therapy, +1 more type
A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
city
~43 mi. (Tyler, Texas, +271 more cities)
facility
The University of Texas Health Science Center at Tyler DBA UT Health East Texas Hope Cancer Center
drug
docetaxel, +2 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
city
~43 mi. (Tyler, Texas, +207 more cities)
facility
Texas Oncology-Tyler ( Site 8006)
biomarker
ER Positive, +1 more biomarker
drug
cyclophosphamide, +6 more drugs
drug type
chemotherapy, +3 more types
Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer
city
~43 mi. (Tyler, Texas, +143 more cities)
facility
UT Health East Texas Hope Cancer Center
drug
carboplatin, +3 more drugs
drug type
chemotherapy, +2 more types
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
city
~43 mi. (Tyler, Texas, +314 more cities)
facility
Texas Oncology-Tyler
biomarker
ATM Loss, +61 more biomarkers
drug
abiraterone, +2 more drugs
drug type
hormone therapy, +1 more type